Sanchari Bhattacharyya
Novartis (Switzerland)(CH)Harvard University(US)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, RNA modifications and cancer, Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Cancer-related gene regulation
Most-Cited Works
- → TET1 is a tumor suppressor of hematopoietic malignancy(2015)225 cited
- → TET1-Mediated Hydroxymethylation Facilitates Hypoxic Gene Induction in Neuroblastoma(2014)170 cited
- → Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts(2019)163 cited
- → Alterations in the ribosomal machinery in cancer and hematologic disorders(2012)121 cited
- → Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma(2019)110 cited
- → Myeloma Is Characterized by Stage-Specific Alterations in DNA Methylation That Occur Early during Myelomagenesis(2013)103 cited
- → Protein Homeostasis Imposes a Barrier on Functional Integration of Horizontally Transferred Genes in Bacteria(2015)98 cited
- → Accessibility of the Shine-Dalgarno Sequence Dictates N-Terminal Codon Bias in E. coli(2018)82 cited
- → Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways(2017)81 cited
- → Transient protein-protein interactions perturb E. coli metabolome and cause gene dosage toxicity(2016)80 cited